logo

Travere Therapeutics Inc (TVTX) Stock: A Year of Stock Market Ups and Downs

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Travere Therapeutics Inc’s current trading price is -70.68% away from its 52-week high, while its distance from the 52-week low is 27.05%. The stock’s price range for this time frame has been between $5.25 and $22.75. The trading volume of the company’s shares in the Healthcare reached around 2.54 million for the day, which was evidently higher than the average daily volume of 1.18 million over the last three months.

In terms of market performance, Travere Therapeutics Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $22.75 on 05/01/23, while the lowest value was $5.25 on 11/10/23.

How Financial Performance Impacts Market Capitalization

Travere Therapeutics Inc (TVTX) has experienced a quarterly decline of -31.94% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 507.59M and boasts a workforce of 380 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 8.05, with a change in price of +0.58. Similarly, Travere Therapeutics Inc recorded 1,354,129 in trading volume during the last 100 days, posting a change of +9.52%.

How TVTX’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for TVTX stands at 2.02. Similarly, the long-term debt-to-equity ratio is also 1.99.

TVTX Stock Stochastic Average

The raw stochastic average for Travere Therapeutics Inc over the last 50 days is presently at 8.60%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 12.12%. Further, the company’s Stochastic %K and %D values for the last 20 days were 13.01% and 13.14%, respectively.

TVTX Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant loss of -25.81% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -6.32%. Over the past 30 days, the price of TVTX has leaped by -16.52%. And in the last five days, it has fallen by -4.44%.